Diagnos Inc. Advances Regulatory Pathway for CARA AI Eye Health Platform in Key Global Markets
Diagnos Inc. has made significant progress in regulatory submissions for its CARA artificial intelligence platform designed for early detection of eye-related health issues, with formal applications underway in Saudi Arabia, Canada, and the United States, positioning the technology for potential commercialization in major healthcare markets.
Read the full story
























